GREENFIELD, Ind. — The U.S. Food and Drug Administration (FDA) has approved the combination feeding of Pulmotil, an in-feed bovine respiratory disease (BRD) treatment, with Rumensin, an efficiency-enhancing feed additive manufactured by Elanco Animal Health.
Approved by the FDA in late 2011, Pulmotil (tilmicosin) is also manufactured by Elanco. It is a BRD treatment for groups of cattle in the early stages of an outbreak that provides 14 days of sustained in-feed therapy, a practice that reduces stress associated with cattle handling.
Pulmotil expands BRD control beyond the chute by providing another option for groups of cattle not requiring a metaphylaxis treatment on arrival and/or when labor resources are limited.
By feeding Pulmotil, producers can reduce pulls, while requiring less individual animal management.
Similar to the prescription requirement for injectable products, the FDA requires a veterinarian to issue a Veterinary Feed Directive (VFD) for the use of Pulmotil to help ensure veterinarian oversight and judicious use of Pulmotil according to the label use and feeding directions.